Blog
1012 Articles
NAPOLI-3 Trial Meets Primary Endpoint in Metastatic Disease
Dr. Tanios Bekaii-Saab explains the early positive results from the NAPOLI-3 clinical trial, testing the NALIRIFOX combination.
Let’s Win Pancreatic Cancer Survivors Series—Year Six
Join Let’s Win’s long-term survivors as they share their uplifting stories of treatment, resilience, and life after pancreatic cancer.
Forget Stages . . . Set Goals Instead!
After her pancreatic cancer diagnosis, Heather Sanderson set goals: surgery and then getting back to the gym.
What Is Pancreatic Cancer?
Learn more about the main different types of pancreatic cancer–adenocarcinoma and pancreatic neuroendocrine tumors.
Meet the Researcher: Jeffrey Patterson-Fortin, M.D., Ph.D.
Researcher Dr. Jeffrey Patterson-Fortin focuses on DNA damage repair as he looks for better pancreatic cancer treatments.
Being Persistent Led to my Cancer Diagnosis
Rod Devlin wasn’t getting an answer to his pain but he was persistent until he finally found a doctor that would give him a scan.
Let’s Win Pancreatic Cancer Launches an Updated Platform
Let’s Win Pancreatic Cancer has launched its new website, with more ways for patients and caregivers to find important information they need.
Early Detection Saved My Life
Martin Abrams and his daughter Tova have a family history of pancreatic cancer, so a screening program and early detection are paramount.
Meet the Researcher: Arnav Mehta, M.D., Ph.D.
Dr. Arnav Mehta combines mathematics and medicine in his search to improve options for gastrointestinal cancer patients. Learn about his groundbreaking work.
Advocating for My Husband has Made the Difference
Nora Mendez had to learn how to advocate for her husband Hector to get him the best possible treatment for stage IV pancreatic cancer.
For Tommy Thompson, the Commitment to Pancreatic Cancer Research Is Personal
Former Wisconsin Governor Tommy Thompson is an advocate for pancreatic cancer research because he lost both his brothers to the disease.
Putting Familial Risk In Perspective
Dr. Alison Klein works to understand the relationship between familial risk and the chances of developing pancreatic cancer.
Urinary Tract Scans Lead to My Diagnosis
Ellen Robbins has the BRCA2 mutation, and that allowed her to participate in a clinical trial for her pancreatic cancer.
Compassionate Use: An Option Beyond Standard of Care
Investigational drugs can be accessed through the FDA’s compassionate use program. Learn more about how this can be used in pancreatic cancer treatments.
Symptoms and Risk Factors
Moderator Daniel G Garza leads Dr. Rachna Shroff and Dr. Fiyinfolu Balogun in a discussion of risk factors and symptoms of pancreatic cancer.